M Ross

643 total citations
9 papers, 554 citations indexed

About

M Ross is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, M Ross has authored 9 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Endocrinology, Diabetes and Metabolism and 2 papers in Genetics. Recurrent topics in M Ross's work include Growth Hormone and Insulin-like Growth Factors (8 papers), Metabolism, Diabetes, and Cancer (6 papers) and Thyroid Disorders and Treatments (3 papers). M Ross is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (8 papers), Metabolism, Diabetes, and Cancer (6 papers) and Thyroid Disorders and Treatments (3 papers). M Ross collaborates with scholars based in Australia. M Ross's co-authors include F J Ballard, Geoffrey L. Francis, John C. Wallace, László Szabó, J. R. E. Wells, Bruce L. May, Steven J. Milner, Kerrie A. McNeil, C.J. Bagley and Christopher J. Bagley and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

M Ross

9 papers receiving 542 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Ross Australia 8 445 347 131 93 68 9 554
Steven J. Milner Australia 7 259 0.6× 254 0.7× 53 0.4× 59 0.6× 59 0.9× 12 377
J R Hembree United States 12 149 0.3× 270 0.8× 76 0.6× 74 0.8× 47 0.7× 13 431
Noboru Egashira Japan 13 271 0.6× 247 0.7× 93 0.7× 61 0.7× 92 1.4× 21 555
Walker Busby United States 6 219 0.5× 179 0.5× 35 0.3× 88 0.9× 24 0.4× 7 338
GE-MING LUI United States 8 105 0.2× 223 0.6× 78 0.6× 64 0.7× 29 0.4× 8 502
Esra Karaköse United States 12 144 0.3× 210 0.6× 178 1.4× 31 0.3× 252 3.7× 16 493
Zong-Ming Feng United States 11 34 0.1× 303 0.9× 107 0.8× 63 0.7× 48 0.7× 14 450
Laura Panacchia Italy 7 92 0.2× 202 0.6× 41 0.3× 28 0.3× 55 0.8× 7 422
Mark E. Hutchin United States 6 92 0.2× 289 0.8× 133 1.0× 30 0.3× 48 0.7× 7 465
Fred Kruse United States 8 33 0.1× 215 0.6× 157 1.2× 67 0.7× 155 2.3× 8 370

Countries citing papers authored by M Ross

Since Specialization
Citations

This map shows the geographic impact of M Ross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Ross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Ross more than expected).

Fields of papers citing papers by M Ross

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Ross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Ross. The network helps show where M Ross may publish in the future.

Co-authorship network of co-authors of M Ross

This figure shows the co-authorship network connecting the top 25 collaborators of M Ross. A scholar is included among the top collaborators of M Ross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Ross. M Ross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Francis, Geoffrey L., M Ross, F J Ballard, et al.. (1992). Novel recombinant fusion protein analogues of insulin-like growth factor (IGF)-I indicate the relative importance of IGF-binding protein and receptor binding for enhanced biological potency. Journal of Molecular Endocrinology. 8(3). 213–223. 161 indexed citations
3.
McKinnon, Peter J., M Ross, J. R. E. Wells, F J Ballard, & Geoffrey L. Francis. (1991). Expression, purification and characterization of secreted recombinant human insulin-like growth factor-I (IGF-I) and the potent variant des(1–3)IGF-I in Chinese hamster ovary cells. Journal of Molecular Endocrinology. 6(3). 231–239. 7 indexed citations
4.
Moss, Jason A., Geoffrey L. Francis, M Ross, John C. Wallace, & F J Ballard. (1991). Insulin-like growth factor (IGF)-I and IGF-II binding to an IGF binding protein. An investigation using chemical modification of tyrosine residues as a structural probe for the sites of interaction.. Journal of Biological Chemistry. 266(2). 909–914. 16 indexed citations
5.
Bagley, C.J., Bruce L. May, László Szabó, et al.. (1989). A key functional role for the insulin-like growth factor 1 N-terminal pentapeptide. Biochemical Journal. 259(3). 665–671. 59 indexed citations
6.
Ross, M, Geoffrey L. Francis, László Szabó, John C. Wallace, & F J Ballard. (1989). Insulin-like growth factor (IGF)-binding proteins inhibit the biological activities of IGF-1 and IGF-2 but not des-(1-3)-IGF-1. Biochemical Journal. 258(1). 267–272. 132 indexed citations
7.
Ross, M & F J Ballard. (1988). Regulation of protein metabolism and DNA synthesis by fibroblast growth factor in BHK-21 cells. Biochemical Journal. 249(2). 363–368. 2 indexed citations
8.
Ballard, F J, M Ross, Zee Upton, & Geoffrey L. Francis. (1988). Specific binding of insulin-like growth factors 1 and 2 to the type 1 and type 2 receptors respectively. Biochemical Journal. 249(3). 721–726. 41 indexed citations
9.
Ballard, F J, Geoffrey L. Francis, M Ross, et al.. (1987). Natural and synthetic forms of insulin-like growth factor-1 (IGF-1) and the potent derivative, destripeptide IGF-1: Biological activities and receptor binding. Biochemical and Biophysical Research Communications. 149(2). 398–404. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026